CYSTEINE-OPTIMIZED STRADOMERS
The present disclosure involves biologically active proteins termed cysteine-optimized multimerizing stradomers. Thus, the present disclosure provides compositions and methods providing anti-autoimmune and anti-inflammatory activities, useful in the treatment of diseases and conditions including aut...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
31.05.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure involves biologically active proteins termed cysteine-optimized multimerizing stradomers. Thus, the present disclosure provides compositions and methods providing anti-autoimmune and anti-inflammatory activities, useful in the treatment of diseases and conditions including autoimmune diseases, inflammatory diseases, or infectious diseases. |
---|---|
Bibliography: | Application Number: EP20170810971 |